http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021378970-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fadbd77025456d2d220897a37044a4ee
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
filingDate 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3adce2ae7a6512ac9e4bf23bda1ae67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a372925febc22cbe0ccdefc33f738a4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b492ee55452080dc8c55bee9b8e8de11
publicationDate 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021378970-A1
titleOfInvention Pharmaceutical dosage form for an emulsion of simethicone and loperamide
abstract A pharmaceutical dosage form comprises a capsule shell and a fill composition, wherein the fill composition comprises an emulsion of (a) simethicone, (b) loperamide or a pharmaceutically acceptable salt thereof, and (c) at least two surfactants, wherein the emulsion has a hydrophilic lipophilic balance ranging from about 8 to about 12. Also described are methods of making the pharmaceutical dosage forms and methods for treating humans suffering from gastrointestinal distress.
priorityDate 2018-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016331684-A9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014005262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014271832-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014275246-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3376199-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227552018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46780460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12209349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10224496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID377079155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7059415

Total number of triples: 92.